Endpoints News
But drug being a small molecule gives it production edge Read in browser
Endpoints News
ALERT
Thank you for reading, dupa dupackia!
basic
UPGRADE
Breaking News

Eli Lil­ly’s GLP-1 pill al­lowed obese pa­tients to lose up to 11.2% of their body weight af­ter 72 weeks of treat­ment, the com­pa­ny said Thurs­day. This is low­er than the bench­mark of about 15% that an­a­lysts had been ex­pect­ing — and it is al­so low­er than the weight loss seen with a ri­val pill from No­vo Nordisk...

Read the full story
Endpoints News
2029 Becker Drive; Lawrence, Kansas 66047 USA Privacy and deletion: help@endpointsnews.com
web twitter linkedin
Worldwide made. Thanks for reading.
Unsubscribe preferences
Unsubscribe from all newsletters
FT Specialist Logo A service from the Financial Times